RespireRx Pharmaceuticals Inc (RSPI): The Cortex website News section has the...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	153
Boards Moderated	0
Alias Born	10/25/2006

K-G

Re: None

Monday, 03/12/2007 8:52:30 PM

Monday, March 12, 2007 8:52:30 PM

The Cortex website News section has the Schering-Plough acquisition of Organon news release with the following preface:

News
Alliance:
Cortex Pharmaceuticals has licensed its AMPAKINE® technology for the treatment of schizophrenia and depression to Organon BioSciences N.V. Organon BioSciences is currently a pharmaceutical business unit of Netherlands-based Akzo Nobel, which recently announced the proposed sale of Organon to Schering-Plough Corporation. Organon BioSciences has two low impact Ampakine compounds (Org.24448 & Org.26576) in clinical trials for the treatment of schizophrenia and depression. In addition, Cortex recently ended a research collaboration with Servier Laboratories. Servier retains the right to select up to three compounds for further development in the areas of neurodegenerative diseases such as AD and Parkinson’s disease. Cortex may receive additional milestones and royalties if either Organon or Servier is successful in the development and commercialization of Ampakine compounds.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM